
Navidea Biopharmaceuticals Inc
OTC:NAVB

Fundamental Analysis


Revenue & Expenses Breakdown
Navidea Biopharmaceuticals Inc
Balance Sheet Decomposition
Navidea Biopharmaceuticals Inc
Current Assets | 4.5m |
Cash & Short-Term Investments | 3.9m |
Receivables | 30.9k |
Other Current Assets | 607.3k |
Non-Current Assets | 1.2m |
PP&E | 119.4k |
Intangibles | 1.1m |
Other Non-Current Assets | 11.8k |
Free Cash Flow Analysis
Navidea Biopharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Navidea Biopharmaceuticals Inc
Revenue
|
0
USD
|
Cost of Revenue
|
-50k
USD
|
Gross Profit
|
-50k
USD
|
Operating Expenses
|
-10.1m
USD
|
Operating Income
|
-10.2m
USD
|
Other Expenses
|
8.8m
USD
|
Net Income
|
-1.4m
USD
|
NAVB Profitability Score
Profitability Due Diligence
Navidea Biopharmaceuticals Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Score
Navidea Biopharmaceuticals Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
NAVB Solvency Score
Solvency Due Diligence
Navidea Biopharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Score
Navidea Biopharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NAVB Price Targets Summary
Navidea Biopharmaceuticals Inc
Dividends
Current shareholder yield for NO1A is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?